Influence of the joint treatment with granulocyte colony-stimulating factor and drugs elevating extracellular adenosine on erythropoietic recovery following 5-fluorouracil-induced haematotoxicity in mice
Language English Country Great Britain, England Media print
Document type Journal Article, Research Support, Non-U.S. Gov't
- MeSH
- Adenosine metabolism pharmacology MeSH
- Adenosine Monophosphate pharmacology therapeutic use MeSH
- Antimetabolites toxicity MeSH
- Time Factors MeSH
- Dipyridamole pharmacology therapeutic use MeSH
- Erythrocytes cytology drug effects MeSH
- Erythroid Precursor Cells cytology drug effects MeSH
- Erythropoiesis drug effects MeSH
- Granulocyte Colony-Stimulating Factor pharmacology therapeutic use MeSH
- Fluorouracil toxicity MeSH
- Hemoglobins drug effects metabolism MeSH
- Phosphodiesterase Inhibitors pharmacology therapeutic use MeSH
- Drug Therapy, Combination MeSH
- Mice, Inbred C57BL MeSH
- Mice, Inbred CBA MeSH
- Mice MeSH
- Erythrocyte Count MeSH
- Reticulocytes cytology drug effects MeSH
- Animals MeSH
- Check Tag
- Male MeSH
- Mice MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- Adenosine MeSH
- Adenosine Monophosphate MeSH
- Antimetabolites MeSH
- Dipyridamole MeSH
- Granulocyte Colony-Stimulating Factor MeSH
- Fluorouracil MeSH
- Hemoglobins MeSH
- Phosphodiesterase Inhibitors MeSH
The presented data address the problem of pleiotropic effects of granulocyte colony-stimulating factor (G-CSF) and suggest the ability of drugs increasing the level of extracellular adenosine to activate erythropoiesis when given jointly with G-CSF. To demonstrate these interactions, the effects of the drugs on the recovery from erythropoietic damage induced in mice by a single dose of 5-fluorouracil (5-FU) were investigated. Elevation of extracellular adenosine and thus activation of adenosine receptors was induced by joint administration of dipyridamole (DP), a drug inhibiting the cellular uptake of adenosine, and adenosine monophosphate (AMP), an adenosine prodrug. The drugs were injected in a 4-d treatment regimen starting 2 h after 5-FU injection. Both DP+AMP and G-CSF alone induced only weak effects. However, the combination of the three drugs produced significant elevation of erythrocytes in the peripheral blood which pertained in the posttreatment period. Stimulation of proliferation of erythroid progenitor cells (BFU-E) in femoral bone marrow and increased levels of reticulocytes in the peripheral blood were observed in the course of the 4-d treatment regimen. In addition, significantly decreased mean cell haemoglobin accompanying the elevated numbers of erythrocytes in the combination-treated mice was found. This effect could be interpreted as the result of a sublethal 5-FU-induced damage to erythroid progenitor and precursor cells forced to proliferate intensively by the combination therapy. The observed additivity and synergism of G-CSF with elevated extracellular adenosine in terms of erythropoiesis is an interesting finding with potential implications in clinical practice.
References provided by Crossref.org
Lack of adenosine A3 receptors causes defects in mouse peripheral blood parameters
The role of adenosine receptor agonists in regulation of hematopoiesis
